Texas Permanent School Fund Corp Sells 1,563 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Texas Permanent School Fund Corp decreased its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 2.3% in the second quarter, HoldingsChannel reports. The institutional investor owned 67,309 shares of the company’s stock after selling 1,563 shares during the period. Texas Permanent School Fund Corp’s holdings in AdaptHealth were worth $819,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC raised its holdings in shares of AdaptHealth by 610.0% in the 1st quarter. Tower Research Capital LLC TRC now owns 3,394 shares of the company’s stock valued at $42,000 after purchasing an additional 2,916 shares in the last quarter. Dark Forest Capital Management LP raised its holdings in shares of AdaptHealth by 31,871.4% in the 1st quarter. Dark Forest Capital Management LP now owns 4,476 shares of the company’s stock valued at $56,000 after purchasing an additional 4,462 shares in the last quarter. Group One Trading L.P. raised its holdings in shares of AdaptHealth by 134.3% in the 1st quarter. Group One Trading L.P. now owns 3,720 shares of the company’s stock valued at $60,000 after purchasing an additional 2,132 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of AdaptHealth by 49.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 3,675 shares of the company’s stock valued at $71,000 after purchasing an additional 1,209 shares in the last quarter. Finally, KBC Group NV bought a new stake in shares of AdaptHealth in the 2nd quarter valued at about $78,000. Institutional investors own 82.67% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Truist Financial reduced their price target on shares of AdaptHealth from $14.00 to $11.00 and set a “buy” rating for the company in a report on Wednesday, November 8th. Royal Bank of Canada cut their price objective on shares of AdaptHealth from $18.00 to $13.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 8th. Finally, Bank of America downgraded shares of AdaptHealth from a “neutral” rating to an “underperform” rating and cut their price objective for the stock from $9.50 to $6.50 in a research report on Wednesday, November 8th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $13.83.

AdaptHealth Trading Down 0.1 %

NASDAQ:AHCO opened at $8.52 on Tuesday. The company has a market capitalization of $1.16 billion, a P/E ratio of -2.49 and a beta of 0.84. The company has a current ratio of 1.31, a quick ratio of 1.05 and a debt-to-equity ratio of 1.23. AdaptHealth Corp. has a 12 month low of $6.37 and a 12 month high of $23.00. The firm has a fifty day simple moving average of $8.17 and a 200-day simple moving average of $10.54.

AdaptHealth (NASDAQ:AHCO) last posted its quarterly earnings results on Tuesday, November 7th. The company reported $0.19 earnings per share for the quarter, meeting the consensus estimate of $0.19. AdaptHealth had a positive return on equity of 4.09% and a negative net margin of 13.68%. The business had revenue of $804.03 million for the quarter, compared to the consensus estimate of $796.60 million. During the same quarter in the previous year, the business earned $0.11 EPS. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, equities research analysts anticipate that AdaptHealth Corp. will post -1.27 earnings per share for the current year.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.